FDA Finally Rescinds Avastin Approval

by Kathy Jones on  November 19, 2011 at 9:03 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

In a major setback for American biotechnology company Genentech, the US Food and Drug Administration has rescinded its approval for Avastin as a mode of treatment for breast cancer.
 FDA Finally Rescinds Avastin Approval
FDA Finally Rescinds Avastin Approval

Avastin had been given approval by the FDA to be used in treating breast cancer patients back in 2008. However further studies have shown that the drug does not increase the lifespan or provide any benefits for patients with breast cancer to justify the risks for taking the drug.

The drug works by starving the cancer cells by stopping the blood supply but comes with a number of serious side effects including severe high blood pressure, massive bleeding, heart attack or heart failure and tissue tears in the stomach and intestines.

"With so much at stake, patients and their doctors count on the FDA to ensure the drugs they use have been shown to be safe and effective for their intended use. Sometimes, the results of rigorous testing can be disappointing", FDA commissioner Margaret Hamburg told the Associated Press.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive